Enzyme
Enzyme provides a comprehensive infrastructure suite for creating, managing, and administering tokenized financial products and decentralized strategies.
Overview
Enzyme is a modular and comprehensive platform designed to empower businesses and institutions to create, manage, and scale tokenized financial products and decentralized investment strategies. It offers a suite of interoperable products including Enzyme Onyx, a Vault as a Service (VaaS) solution for issuing and administering tokenized funds and instruments; Enzyme Blue, a platform for curating and managing decentralized strategies; and Enzyme Myso, a protocol for creating and trading on-chain covered calls and cash-secured puts. These products enable enterprises to deploy institutional-grade tokenized vehicles with advanced administrative controls and compliance-ready infrastructure.
The platform targets a broad range of users including product issuers, financial service providers, asset managers, fund platforms, custodians, brokers, neobanks, and exchanges. Enzyme’s infrastructure supports regulatory compliance with AML/CTF, investor whitelisting, and transaction monitoring aligned with global standards such as MiFID II, CAR, AIFMD, UCITS, SEC regulations, and FCA frameworks. This makes it suitable for regulated financial institutions seeking to integrate decentralized finance (DeFi) capabilities into their offerings.
What sets Enzyme apart is its mature, battle-tested technology stack with over eight years of experience in decentralized finance, a strong security record with no breaches, and a track record of rigorous audits. Its products streamline operations by integrating with 30+ protocols and hundreds of assets, offering built-in analytics, delegation, and automation features. Enzyme’s white-label solutions allow clients to deliver seamless investor experiences while maintaining full control over fund administration and compliance. Adoption metrics include over $7 billion in total transaction volume and $200 million in assets under technology, underscoring its enterprise-grade reliability.
Developers and institutions can get started by exploring Enzyme’s detailed documentation and developer tools, including APIs and SDKs, to integrate tokenized finance capabilities. The platform’s modular design supports flexible deployment, whether for tokenized funds, financial instruments, or decentralized strategy management. Enzyme also offers a grant program and active community channels to support innovation and collaboration.
The Problem
Traditional financial institutions and asset managers face challenges integrating decentralized finance due to fragmented infrastructure, regulatory compliance complexities, and lack of scalable, secure tokenization tools. Managing tokenized funds and financial instruments on-chain requires robust, compliant, and flexible platforms that can handle diverse asset types and investor requirements.
The Solution
Key Features
Vault as a Service (Onyx)
Institutional-grade platform to issue, structure, and administer tokenized funds and instruments with full administrative control.
Enzyme Alternatives
Explore web3 competitors and apps like Enzyme.
Firebird Finance
Pricing
Onyx Pricing | |
|---|---|
| Price (Monthly) | Custom pricing |
| Price (Annual) | Custom pricing |
| Messaging | N/A |
| Support | Dedicated enterprise support available |
| Analytics |
Start Building Now
Reliable RPC, powerful APIs, and zero hassle.
Resources
Enzyme provides extensive developer documentation, including user guides, API references, SDKs, and security audits. The documentation covers all products and use cases, enabling developers and institutions to integrate and build on Enzyme’s tokenized finance infrastructure efficiently.
